©The Author(s) 2026.
World J Cardiol. Feb 26, 2026; 18(2): 114636
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114636
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114636
Table 3 Cumulative clinical outcomes
| Clinical events | n (%) |
| MACE | 32 (4.32) |
| Cardiac death | 19 (2.57) |
| TLR/TVR | 13 (1.76) |
| Target vessel MI (without TLR/TVR or mortality) | 0 (0.00) |
| Non-cardiac death | 35 (4.73) |
| NYHA I/II without TLR/TVR | 673 (90.95) |
- Citation: Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS. Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. World J Cardiol 2026; 18(2): 114636
- URL: https://www.wjgnet.com/1949-8462/full/v18/i2/114636.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i2.114636